UK markets close in 34 minutes

CMG Pharmaceutical Co., Ltd. (058820.KQ)

KOSDAQ - KOSDAQ Delayed price. Currency in KRW
Add to watchlist
2,080.000.00 (0.00%)
At close: 03:30PM KST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
6,000,368
6,455,349
-388,140
3,165,485
214,996
-
Depreciation & amortisation
-
2,557,567
2,284,322
2,491,431
2,435,529
-
Stock-based compensation
-
60,294
26,645
16,478
389,355
-
Change in working capital
-
-7,658,281
-4,303,844
-1,469,547
-4,990,499
-
Inventory
-
-497,724
-8,857,468
839,152
-6,891,241
-
Other working capital
-
-11,336,538
-5,369,992
1,677,419
-6,706,207
-
Other non-cash items
-
-3,672,896
-1,947,873
-1,763,992
-817,979
-
Net cash provided by operating activities
-
3,909,002
4,937,550
5,628,620
2,944,289
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-15,245,540
-10,307,542
-3,951,201
-9,650,496
-
Acquisitions, net
-
-3,129,212
-
-
-5,407,262
-
Purchases of investments
-
-112,629,694
-94,110,413
-66,824,820
-81,288,152
-
Sales/maturities of investments
-
95,795,735
97,595,775
69,289,973
84,326,280
-
Other investing activities
-
-45,000
49,000
-4,000
-2,268
-
Net cash used for investing activities
-
-28,220,842
-10,867,979
-8,480,048
-13,008,899
-
Net change in cash
-
-3,213,277
-303,225
-3,285,216
-10,526,355
-
Cash at beginning of period
-
4,455,797
4,759,022
8,044,237
18,570,592
-
Cash at end of period
-
1,242,520
4,455,797
4,759,022
8,044,237
-
Free cash flow
Operating cash flow
-
3,909,002
4,937,550
5,628,620
2,944,289
-
Capital expenditure
-
-15,245,540
-10,307,542
-3,951,201
-9,650,496
-
Free cash flow
-
-11,336,538
-5,369,992
1,677,419
-6,706,207
-